• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD UNKN BIRMINGHAM HIP RESURFACING (BHR) CUP (UNKN TYPE); PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD UNKN BIRMINGHAM HIP RESURFACING (BHR) CUP (UNKN TYPE); PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Catalog Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hematoma (1884)
Event Date 07/27/2007
Event Type  Injury  
Manufacturer Narrative
Internal complaint reference: (b)(4).
 
Event Description
It was reported that, after a bhr resurfacing primary surgery had been performed on the patient¿s right hip on (b)(6) 2007, the patient required an immediate washout procedure due to a postoperative hematoma.Additional details regarding this intervention are not known.
 
Manufacturer Narrative
It was reported that the patient required an immediate washout procedure due to a postoperative hematoma.Additional details regarding this intervention are not known and the devices, used in treatment, are presumed to still be implanted.As no device part and batch numbers were provided for investigation, a complaint history review, manufacturing record review, device labelling / ifu review could not be performed.If more information is received, this investigation will be reopened.A review of historic escalation actions related to the products and similar complaint events was performed.No prior applicable escalation actions were identified and no further escalation actions are required.A risk management review was performed for the acetabular cup.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A physician¿s note 10 years post implantation noted, ¿he has no history of infection, but he did have a history of an immediate washout for a hematoma several days after the initial surgery.¿ no other documentation regarding this event was provided.With the limited information provided, the clinical root cause of the reported hematoma and subsequent washout cannot be confirmed; however, the hematoma is a known complication of surgery and is related to the procedure and not the device.The patient impact beyond the hematoma and washout cannot be determined.Based on the reported operative notes we can confirm the complaint, however without additional information we cannot further investigate the reported issue.Based on the information provided, the probable root cause is that the issue is not related to the device and seems to have been caused by something other than the device or usage.If the products or additional information become available in the future, this case will be reopened.Based on this investigation, the need for corrective or preventative action is not indicated.
 
Manufacturer Narrative
H3, h6: it was reported that the patient required an immediate washout procedure due to a postoperative hematoma.Additional details regarding this intervention are not known and the devices, used in treatment, are presumed to still be implanted.As no device part and batch numbers were provided for investigation, a complaint history review, manufacturing record review, device labelling / ifu review could not be performed.If more information is received, this investigation will be reopened.A review of historic escalation actions related to the products and similar complaint events was performed.No prior applicable escalation actions were identified and no further escalation actions are required.A risk management review was performed for the acetabular cup.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A physician¿s note 10 years post implantation noted, ¿he has no history of infection, but he did have a history of an immediate washout for a hematoma several days after the initial surgery.¿ no other documentation regarding this event was provided.With the limited information provided, the clinical root cause of the reported hematoma and subsequent washout cannot be confirmed; however, the hematoma is a known complication of surgery and is related to the procedure and not the device.The patient impact beyond the hematoma and washout cannot be determined.Based on the reported operative notes we can confirm the complaint, however without additional information we cannot further investigate the reported issue.Based on the information provided, the probable root cause is that the issue is not related to the device and seems to have been caused by something other than the device or usage.If the products or additional information become available in the future, this case will be reopened.Based on this investigation, the need for corrective or preventative action is not indicated.
 
Manufacturer Narrative
H10 - additional information a4 - patient weight b6 - relevant tests b7 - other relevant history.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKN BIRMINGHAM HIP RESURFACING (BHR) CUP (UNKN TYPE)
Type of Device
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key14973824
MDR Text Key295601107
Report Number3005975929-2022-00418
Device Sequence Number1
Product Code NXT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 06/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/10/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age43 YR
Patient SexMale
Patient Weight66 KG
-
-